{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:28:54Z","timestamp":1787498934686,"version":"build-2736575974"},"reference-count":58,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["22K06707"],"award-info":[{"award-number":["22K06707"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"award":["22K06707"],"award-info":[{"award-number":["22K06707"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Gonadotropin-releasing hormone receptor (GnRHR) agonists are widely used therapeutically, yet their adverse event profile remains insufficiently characterized. We developed a machine-learning model using Tox21 GnRHR agonist activity data and molecular descriptors to predict GnRHR agonist activity among FDA Adverse-Event Reporting System (FAERS)-listed drugs. BalancedRandomForest achieved the highest ROC-AUC (0.810) and was applied to 5523 FAERS-listed drugs. Following applicability-domain assessment, 1191 drugs were retained, of which 367 were predicted to have GnRHR agonist activity. FAERS data from 2004 Q1 through 2024 Q3 were analyzed using reporting odds ratios (RORs) and Fisher\u2019s exact test for MedDRA Preferred Terms (PTs). Overall, 330 unique PTs corresponding to 531 PT\u2013SOC assignments met prespecified criteria: at least 1000 reports, ln(ROR) &gt; 1, and q &lt; 0.05. The highest proportions of significant PTs were observed in respiratory, thoracic and mediastinal disorders; infections and infestations; and hepatobiliary disorders. These findings suggest that drugs predicted to have GnRHR agonist activity may show disproportionate reporting of respiratory, infectious, and hepatobiliary adverse events, although causality cannot be established. This framework may support hypothesis generation and safety signal prioritization during drug development and postmarketing surveillance.<\/jats:p>","DOI":"10.3390\/ijms27156675","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:47:41Z","timestamp":1785145661000},"page":"6675","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of Adverse Events Associated with Predicted GnRHR Agonists Using the FAERS Database"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0372-6955","authenticated-orcid":false,"given":"Yui","family":"Migura","sequence":"first","affiliation":[{"name":"Department of Medical Molecular Informatics, Meiji Pharmaceutical University, Tokyo 204-8588, Japan"},{"name":"Tokushima Research Center for Drug Discovery, Otsuka Pharmaceutical Co., Ltd., Tokushima 771-0192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5773-991X","authenticated-orcid":false,"given":"Yoshihiro","family":"Uesawa","sequence":"additional","affiliation":[{"name":"Department of Medical Molecular Informatics, Meiji Pharmaceutical University, Tokyo 204-8588, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Fanis, P., Neocleous, V., Papapetrou, I., Phylactou, L.A., and Skordis, N. (2023). Gonadotropin-Releasing Hormone Receptor (GnRHR) and Hypogonadotropic Hypogonadism. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242115965"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mce.2017.03.022","article-title":"Regulation of reproduction via tight control of gonadotropin hormone levels","volume":"463","author":"Coss","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.yfrne.2010.04.002","article-title":"GnRH signaling, the gonadotrope and endocrine control of fertility","volume":"31","author":"Bliss","year":"2010","journal-title":"Front. Neuroendocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/molehr\/gap089","article-title":"Demethylation of LHR in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome","volume":"16","author":"Zhu","year":"2010","journal-title":"Mol. Hum. Reprod."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1477-7827-12-86","article-title":"Follicle-stimulating hormone receptor gene polymorphism in chronic anovulatory women, with or without polycystic ovary syndrome: A cross-sectional study","volume":"12","author":"Singhasena","year":"2014","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12958-024-01332-5","article-title":"Triggering final follicular maturation for IVF cycles","volume":"23","author":"Orvieto","year":"2025","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gu, L., Li, X., and Liu, W. (2023). Adverse cardiovascular effect following gonadotropin-releasing hormone antagonist versus GnRH agonist for prostate cancer treatment: A systematic review and meta-analysis. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1157857"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"102770","DOI":"10.1016\/j.ctrv.2024.102770","article-title":"Revisiting ovarian function suppression with GnRH agonists for premenopausal women with breast cancer: Who should use and the impact on survival outcomes","volume":"129","author":"Ma","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"ref_9","first-page":"40","article-title":"GnRH agonists in the treatment of symptomatic endometriosis: A review","volume":"4","author":"Surrey","year":"2022","journal-title":"F S Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11154-021-09666-w","article-title":"Hormonal treatments for endometriosis: The endocrine background","volume":"23","author":"Vannuccini","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/bcp.15336","article-title":"Analysis of adverse event of interstitial lung disease in men with prostate cancer receiving hormone therapy using the Food and Drug Administration Adverse Event Reporting System","volume":"89","author":"Wu","year":"2023","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.juro.2018.03.135","article-title":"Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer","volume":"200","author":"Gild","year":"2018","journal-title":"J. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Chen, Y., Lu, W., Liao, R., Zhang, X., Chen, W., Wang, J., and Feng, H. (2025). Adverse event profile differences among long-acting gonadotropin-releasing hormone analogs: A real-world, pharmacovigilance study. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0327842"},{"key":"ref_14","unstructured":"(2025, January 16). Toxicology in the 21st Century (Tox21)\u2014About Tox21, Available online: https:\/\/tox21.gov\/overview\/about-tox21\/."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"bqae103","DOI":"10.1210\/endocr\/bqae103","article-title":"Identification of Environmental Compounds That May Trigger Early Female Puberty by Activating Human GnRHR and KISS1R","volume":"165","author":"Yang","year":"2024","journal-title":"Endocrinology"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Yamada, S., and Uesawa, Y. (2025). Exploring Adverse Event Associations of Predicted PXR Agonists Using the FAERS Database. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202507.0150.v1"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"109063","DOI":"10.1016\/j.cmpb.2025.109063","article-title":"Integration of nested cross-validation, automated hyperparameter optimization, high-performance computing to reduce and quantify the variance of test performance estimation of deep learning models","volume":"272","author":"Calle","year":"2025","journal-title":"Comput. Methods Programs Biomed."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.envint.2014.12.012","article-title":"PBT assessment and prioritization by PBT Index and consensus modeling: Comparison of screening results from structural models","volume":"77","author":"Gramatica","year":"2015","journal-title":"Environ. Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13321-017-0230-2","article-title":"Efficiency of different measures for defining the applicability domain of classification models","volume":"9","author":"Klingspohn","year":"2017","journal-title":"J. Cheminform."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e2500112122","DOI":"10.1073\/pnas.2500112122","article-title":"Cryo-EM structures of GnRHR: Foundations for next-generation therapeutics","volume":"122","author":"Shen","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1210\/me.2002-0159","article-title":"Conformational constraint of mammalian, chicken, and salmon GnRHs, but not GnRH II, enhances binding at mammalian and nonmammalian receptors: Evidence for preconfiguration of GnRH II","volume":"16","author":"Pfleger","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"38569","DOI":"10.1074\/jbc.M503086200","article-title":"Evolution of constrained gonadotropin-releasing hormone ligand conformation and receptor selectivity","volume":"280","author":"Barran","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/thoraxjnl-2016-209512","article-title":"Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia","volume":"72","author":"Hicks","year":"2017","journal-title":"Thorax"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00066-022-02032-y","article-title":"Systematic risk analysis of radiation pneumonitis in breast cancer: Role of cotreatment with chemo-, endocrine, and targeted therapy","volume":"199","author":"Mangesius","year":"2023","journal-title":"Strahlenther. Onkol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1590\/S0100-879X2000000300004","article-title":"Morphologic and biochemical changes in male rat lung after surgical and pharmacological castration","volume":"33","author":"Ojeda","year":"2000","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/1096-9896(0000)9999:9999<::AID-PATH803>3.0.CO;2-W","article-title":"Localization of androgen receptor expression in human bone marrow","volume":"193","author":"Mantalaris","year":"2001","journal-title":"J. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1093\/humrep\/dei072","article-title":"High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: Normalization with metformin and flutamide overcomes the aggravation by oral contraception","volume":"20","author":"Ibanez","year":"2005","journal-title":"Hum. Reprod."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1084\/jem.20082521","article-title":"Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor","volume":"206","author":"Chuang","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.eururo.2013.02.003","article-title":"Androgen-deprivation therapy and risk for biliary disease in men with prostate cancer","volume":"65","author":"Saylor","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jcem.87.2.8299","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1158\/1078-0432.CCR-11-3209","article-title":"Prospective study of changes in the metabolomic profiles of men during their first three months of androgen deprivation therapy for prostate cancer","volume":"18","author":"Saylor","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_32","first-page":"e76560","article-title":"Non-surgical management of gallstones during pregnancy: A clinical case report","volume":"16","author":"Boicean","year":"2024","journal-title":"Cureus"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1800154","DOI":"10.1002\/minf.201800154","article-title":"Intercorrelation limits in molecular descriptor preselection for QSAR\/QSPR","volume":"38","author":"Racz","year":"2019","journal-title":"Mol. Inform."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.1742","article-title":"Quantitative signal detection using spontaneous ADR reporting","volume":"18","author":"Bate","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1517\/14740338.4.5.929","article-title":"The role of data mining in pharmacovigilance","volume":"4","author":"Hauben","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1248\/yakushi.20-00196-1","article-title":"Role and applicability of spontaneous reporting databases in medical big data","volume":"141","author":"Sakai","year":"2021","journal-title":"Yakugaku Zasshi"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF03256770","article-title":"Evaluation of reporting bias in postmarketing risk assessment based on spontaneous reporting systems","volume":"23","author":"Alemayehu","year":"2009","journal-title":"Pharm. Med."},{"key":"ref_38","first-page":"115","article-title":"Effect of competition bias in safety signal generation: Analysis of a research database of spontaneous reports in France","volume":"26","author":"Pariente","year":"2012","journal-title":"Pharm. Med."},{"key":"ref_39","unstructured":"(2025, December 15). RDKit. RDKit Documentation. Available online: https:\/\/www.rdkit.org\/docs\/index.html."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1021\/acs.jcim.5b00654","article-title":"Better Informed Distance Geometry: Using What We Know To Improve Conformation Generation","volume":"55","author":"Riniker","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13321-014-0037-3","article-title":"Bringing the MMFF force field to the RDKit: Implementation and validation","volume":"6","author":"Tosco","year":"2014","journal-title":"J. Cheminform."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13321-018-0258-y","article-title":"Mordred: A molecular descriptor calculator","volume":"10","author":"Moriwaki","year":"2018","journal-title":"J. Cheminform."},{"key":"ref_43","unstructured":"(2025, December 15). Mordred-Community. Available online: https:\/\/github.com\/JacksonBurns\/mordred-community."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"key":"ref_45","unstructured":"Ke, G., Meng, Q., Finley, T., Wang, T., Chen, W., Ma, W., Ye, Q., and Liu, T.Y. LightGBM: A Highly Efficient Gradient Boosting Decision Tree. Proceedings of the 31st International Conference on Neural Information Processing Systems."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Chen, T., and Guestrin, C. (2016). XGBoost: A scalable tree boosting system. arXiv.","DOI":"10.1145\/2939672.2939785"},{"key":"ref_47","first-page":"1","article-title":"Using random forest to learn imbalanced data","volume":"110","author":"Chen","year":"2004","journal-title":"Univ. Calif. Berkeley"},{"key":"ref_48","unstructured":"(2025, December 15). Optuna. Available online: https:\/\/www.optuna.org\/."},{"key":"ref_49","first-page":"4765","article-title":"A Unified Approach to Interpreting Model Predictions","volume":"Volume 30","author":"Lundberg","year":"2017","journal-title":"Advances in Neural Information Processing Systems"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0005-2795(75)90109-9","article-title":"Comparison of the predicted and observed secondary structure of T4 phage lysozyme","volume":"405","author":"Matthews","year":"1975","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","article-title":"An Introduction to ROC analysis","volume":"27","author":"Fawcett","year":"2006","journal-title":"Pattern Recognit. Lett."},{"key":"ref_52","unstructured":"Davis, J., and Goadrich, M. The relationship between Precision\u2013Recall and ROC curves. Proceedings of the 23rd International Conference on Machine Learning."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bimj.200410135","article-title":"Estimation of the Youden index and its associated cutoff point","volume":"47","author":"Fluss","year":"2005","journal-title":"Biom. J."},{"key":"ref_54","unstructured":"U.S. Food and Drug Administration (2025, July 26). FDA Adverse Event Reporting System (FAERS) Database, Available online: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-adverse-event-reporting-system-faers-database."},{"key":"ref_55","unstructured":"Swain, M. (2025, July 25). PubChemPy: A Way to Interact with PubChem in Python. Available online: https:\/\/github.com\/mcs07\/pubchempy."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jrsm.1460","article-title":"Zero-cell corrections in random-effects meta-analyses","volume":"11","author":"Weber","year":"2020","journal-title":"Res. Synth. Methods"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/bcp.15802","article-title":"Considerations on the use of different comparators in pharmacovigilance: A methodological review","volume":"89","author":"Gravel","year":"2023","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6675\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:55:54Z","timestamp":1785146154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":58,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27156675"],"URL":"https:\/\/doi.org\/10.3390\/ijms27156675","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]}}}